Acella Pharmaceuticals, LLC recalls
Every recall we track for Acella Pharmaceuticals, LLC — 16 in all, from 2020–2026 — plus the complaints and injury reports the public filed about them. 3 are rated “stop using now”.
Recalls per year, by danger level
16 recalls since 2017. 19% rated “stop using now”.
All FDA recall records for Acella Pharmaceuticals, LLC since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 3 | 0 | 2 | 0 | 5 |
| 2021 | 0 | 0 | 5 | 0 | 5 |
| 2022 | 0 | 0 | 3 | 0 | 3 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 1 | 0 | 1 |
| 2026 (to date) | 0 | 0 | 0 | 1 | 1 |
Most common reasons for Acella Pharmaceuticals, LLC recalls
What to do if you have a recalled Acella Pharmaceuticals, LLC product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Acella Pharmaceuticals, LLC recalls
8 shown- UnratedDrug
Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals,
Acella Pharmaceuticals recalls 125mg/5mL naproxen suspension bottles due to lead and lithium contamination exceeding safety limits. Consumers should contact the manufacturer for details.
Acella PharmaceuticalsApr 20, 2026 - Lower riskDrug
Acella Pharmaceuticals, LLC recalls Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC,
Acella Pharmaceuticals recalls 100mg doxycycline tablets due to failed dissolution testing. This may affect medication stability. Check NDC 42192-501-05 and lot P24ZLK1 for affected products.
Acella PharmaceuticalsSep 29, 2025 - Lower riskDrug
Acella Pharmaceuticals, LLC recalls Sodium Sulfacetamide 10% - Sulfur 5% Cleanser, Rx Only, 6 oz (170.3 g) Bottle, Manufactured for Acela Pharmaceuticals,
Acella Pharmaceuticals recalls 6 oz Sodium Sulfacetamide 10% - Sulfur 5% Cleanser (Rx Only) for subpotent drug content. This prescription product may not be as effective as intended.
Acella PharmaceuticalsApr 24, 2024 - Lower riskDrug
Acella Pharmaceuticals, LLC recalls Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC
Acella Pharmaceuticals recalls Phenytoin Sodium Injection (250 mg/5 mL) due to missing barcode on primary vial labels. This affects patients using the product for seizures. Contact the manufacturer for details.
Acella PharmaceuticalsNov 14, 2022 - Lower riskDrug
Acella Pharmaceuticals, LLC recalls Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per
Acella Pharmaceuticals recalls 60-count cleansing pads with potential subpotent drug levels. These prescription pads may not contain enough active ingredient by end-of-shelf-life. Consumers should contact the manufacturer for details.
Acella PharmaceuticalsNov 14, 2022 - Lower riskDrug
Acella Pharmaceuticals, LLC recalls NP Thyroid 120 Thyroid Tablets, USP 2 grain (120 mg), packaged in a) 100-count bottles (NDC 42192-328-01) and b)
Acella Pharmaceuticals recalls NP Thyroid 120 tablets (120 mg) due to subpotent drug content. These tablets may not provide the intended thyroid hormone levels. Affected lots expired by August 2021.
Acella PharmaceuticalsApr 29, 2021 - Lower riskDrug
Acella Pharmaceuticals, LLC recalls NP Thyroid 15,Thyroid Tablets, USP 1/4 grain (15 mg) 100-count bottles, Rx Only, Manufactured For: Acella
Acella Pharmaceuticals recalls 100-count NP Thyroid 15 tablets (15 mg) due to subpotent levothyroxine content. FDA analysis shows these products contain less active ingredient than labeled, potentially causing inadequate thyroid hormone levels.
AcellaSep 17, 2020 - Stop using nowDrug
Acella Pharmaceuticals, LLC recalls NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured For: Acella
Acella Pharmaceuticals recalls 100-count NP Thyroid 60 tablets (60 mg) due to superpotent drug risk. Rx-only medication with specific lot numbers and expiration date.
AcellaMay 22, 2020
Acella Pharmaceuticals, LLC recall questions
How many recalls has Acella Pharmaceuticals, LLC had?
16 recalls from Acella Pharmaceuticals, LLC are on record with U.S. safety agencies, from 2020–2026.
What is the most recent Acella Pharmaceuticals, LLC recall?
Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals,, dated Apr 20, 2026. Every Acella Pharmaceuticals, LLC recall is listed on this page, newest first.
Why are Acella Pharmaceuticals, LLC products recalled?
The most common reasons on record: Subpotent Drug (5); Superpotent Drug. (3).
What should I do if I have a recalled Acella Pharmaceuticals, LLC product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Acella Pharmaceuticals, LLC recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.